cell lung trang 13 tải miễn phí từ TAILIEUCHUNG

"cell lung" trang 13 - tải miễn phí từ Tailieuchung

Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer

Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer

8 25 1

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer

8 53 1

RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance

RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance

9 33 1

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

9 47 1

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

7 45 1

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: A diagnostic test study (LACOG 0114)

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: A diagnostic test study (LACOG 0114)

8 57 1

Prophylactic cranial irradiation in small cell lung cancer: A systematic review and metaanalysis

Prophylactic cranial irradiation in small cell lung cancer: A systematic review and metaanalysis

10 31 1

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

9 60 1

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A systematic review

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A systematic review

5 46 1

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

7 50 1

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway

11 26 1

Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

11 70 1

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

8 26 1

EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: A systematic review and metaanalysis

EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: A systematic review and metaanalysis

6 29 1

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

6 30 1

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

8 30 1

Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated

Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated

13 61 1

Serum low-density lipoprotein and lowdensity lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)

Serum low-density lipoprotein and lowdensity lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)

9 39 1

A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer

A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer

8 36 1

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

8 73 1

Đầu
1
2
3
4
5
6
7
8
9
10
11
12
[ 13 ]
14
15
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.